Hemostasis Analyzer Market worth $5.0 billion by 2025
According to market research report the global Hemostasis Analyzers
Market is projected to reach USD 5.0 billion by 2025 from USD 3.8
billion in 2020, at a CAGR of 5.7% between 2020 and 2025.
Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392
The growth of the global Hemostasis Analyzer Market
is largely driven by the increasing prevalence of cardiovascular
diseases and blood disorders, technological advancements in coagulation
analyzers, and the rising geriatric population. Emerging economies and
growing number of reagent rental agreements are expected to offer growth
opportunities to market players in the coming years.
North America is the largest regional market for coagulation analyzers
North America (comprising the US and Canada) accounted for the largest
share of the global Coagulation Analyzer Market in 2019, followed by
Europe. Factors such as the increasing prevalence of lifestyle diseases
and the rising incidence of blood disorders are stimulating the growth
of the market in North America.
Clinical laboratory analyzers dominated the Hemostasis Analyzer Market in 2019
Based on product, the Hemostasis Analyzer Market is segmented into
clinical laboratory analyzers and point-of-care testing analyzers. In
2019, the clinical laboratory analyzers segment accounted for a larger
share of the market. The large share of this segment can be attributed
to factors such as the growing prevalence of blood disorders and
increasing development of automated coagulation systems with faster
turnaround times, compact size, and expanded capabilities.
Optical technology segment accounted for the largest share of the Hemostasis Analyzer Market, by technology, in 2019
The coagulation analyzers available in the market are based on three
major technologies—optical technology, mechanical technology, and
electrochemical technology. However, apart from these technologies,
coagulation analyzers can also be based on other technologies, such as
nephelometric, immunogenic, chromogenic, advanced biosensor, and
thromboelastometry technologies. The most widely used technology in the
Hemostasis Analyzer Market is the optical technology. This segment
accounted for the largest share of the market in 2019.
Clinical laboratories dominated the Hemostasis Analyzer Market in 2019
On the basis of end user, the market is segmented into clinical
laboratories, hospitals, and other end users. In 2019, the clinical
laboratories segment accounted for the largest share of the market.
Request for Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392
Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Roche
Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan),
Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena
Laboratories (US), and Horiba Medical (Japan) are some of the key
players operating in this Hemostasis Analyzer Market.
Comments
Post a Comment